Proteomics: A new dimension to decode small cell lung cancer

Haobin Chen; Benjamin J. Drapkin; John D. Minna

doi:10.1016/j.cell.2023.11.042

Proteomics: A new dimension to decode small cell lung cancer

Haobin Chen, Benjamin J. Drapkin, John D. Minna

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Small cell lung cancer (SCLC) is a recalcitrant malignancy. Conquering it will require deep insight into its biology. In this issue of Cell, Liu and colleagues describe proteomic and phosphoproteomic landscapes of resected SCLC tumors and illustrate the potential of this knowledge to identify new SCLC vulnerabilities.

Original language	English (US)
Pages (from-to)	14-16
Number of pages	3
Journal	Cell
Volume	187
Issue number	1
DOIs	https://doi.org/10.1016/j.cell.2023.11.042
State	Published - Jan 4 2024

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1016/j.cell.2023.11.042

Cite this

@article{7a2bf9480e684c25967876a21fb53f8a,

title = "Proteomics: A new dimension to decode small cell lung cancer",

abstract = "Small cell lung cancer (SCLC) is a recalcitrant malignancy. Conquering it will require deep insight into its biology. In this issue of Cell, Liu and colleagues describe proteomic and phosphoproteomic landscapes of resected SCLC tumors and illustrate the potential of this knowledge to identify new SCLC vulnerabilities.",

author = "Haobin Chen and Drapkin, {Benjamin J.} and Minna, {John D.}",

note = "Publisher Copyright: {\textcopyright} 2023 Elsevier Inc.",

year = "2024",

month = jan,

day = "4",

doi = "10.1016/j.cell.2023.11.042",

language = "English (US)",

volume = "187",

pages = "14--16",

journal = "Cell",

issn = "0092-8674",

publisher = "Cell Press",

number = "1",

}

TY - JOUR

T1 - Proteomics

T2 - A new dimension to decode small cell lung cancer

AU - Chen, Haobin

AU - Drapkin, Benjamin J.

AU - Minna, John D.

PY - 2024/1/4

Y1 - 2024/1/4

N2 - Small cell lung cancer (SCLC) is a recalcitrant malignancy. Conquering it will require deep insight into its biology. In this issue of Cell, Liu and colleagues describe proteomic and phosphoproteomic landscapes of resected SCLC tumors and illustrate the potential of this knowledge to identify new SCLC vulnerabilities.

AB - Small cell lung cancer (SCLC) is a recalcitrant malignancy. Conquering it will require deep insight into its biology. In this issue of Cell, Liu and colleagues describe proteomic and phosphoproteomic landscapes of resected SCLC tumors and illustrate the potential of this knowledge to identify new SCLC vulnerabilities.

UR - http://www.scopus.com/inward/record.url?scp=85181242829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85181242829&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2023.11.042

DO - 10.1016/j.cell.2023.11.042

M3 - Comment/debate

C2 - 38181738

AN - SCOPUS:85181242829

SN - 0092-8674

VL - 187

SP - 14

EP - 16

JO - Cell

JF - Cell

IS - 1

ER -

Proteomics: A new dimension to decode small cell lung cancer

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this